CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
The Director Transplant Operations & Quality will serve as CareDx’s subject matter expert on the transplant patient journey and the operational priorities of transplant centers. This role is critical in shaping product development, messaging, and commercial execution to ensure CareDx delivers solutions that improve transplant outcomes and reduce workflow burden for transplant centers. The individual will collaborate closely with PLM, Marketing and field leadership teams to integrate deep transplant ecosystem insights into product strategy, digital portfolio enhancements, and wrap-around service development, messaging and approach.
Key Responsibilities
- Act as the primary expert on transplant center operations, priorities, and strategic goals to inform product lifecycle decisions.
- Partner with the Digital Portfolio PLM lead to enhance features, functionality, and value proposition of CareDx’s digital solutions.
- Drive development of future wrap-around services and solutions that complement testing services and improve transplant outcomes.
- Provide actionable insights to PLM team members to ensure new products and services align with transplant center workflows and needs.
- Advise Sales, Marketing and PLM teams on messaging and data strategies strategies targeted at transplant center administrators and decision-makers, as well as clinical coordinators as needed.
- Work with Market Access and PLM Teams to advice on product trials, health economic study design and cost modeling that clearly communicates health economic value of our product portfolio to health systems and clinician groups.
- Represent CareDx in external engagements, webinars, etc with transplant center administrators, clinical coordinators, societies, and industry forums focused on improving quality and effectiveness of the transplant ecosystem.
- Collaborate cross-functionally to ensure commercial execution aligns with strategic objectives and customer needs.
Required Qualifications
- Bachelor’s degree in Life Sciences, Healthcare Administration, or related field; advanced degree preferred.
- 10+ years of experience in transplant healthcare, with deep knowledge of transplant center operations and the patient journey.
- Proven track record of influencing product development and commercial strategies in a healthcare or life sciences organization.
- Strong understanding of digital health solutions and their application in clinical workflows.
- Exceptional communication and stakeholder engagement skills, including experience interacting with healthcare administrators and societies.
Preferred Qualifications
- Experience in product management or marketing within the transplant or broader healthcare ecosystem.
- Familiarity with regulatory and compliance requirements in transplant care.
- MBA or equivalent business experience.
Competencies & Attributes
- Strategic thinker with ability to translate insights into actionable plans.
- Strong communicator and influencer
- Highly collaborative and adept at influencing cross-functional teams.
- Strong analytical and problem-solving skills.
- Passion for improving transplant outcomes and reducing workflow burden.
Travel Requirements:
- Up to 30% travel for customer engagement, conferences, and internal meetings.
Additional Details:
Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.
Our competitive Total Rewards package for US Employees includes:
- Competitive base salary and incentive compensation
- Health and welfare benefits, including a gym reimbursement program
- 401(k) savings plan match
- Employee Stock Purchase Plan
- Pre-tax commuter benefits
- And more!
- Please refer to our page to view detailed benefits at https://caredx.com/company/careers
In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.
CareDx, Inc. is an Equal Opportunity Employer and participates in the E-Verify program.
By proceeding with our application and submitting your information, you acknowledge that you have read our U.S. Personnel Privacy Notice and consent to receive email communication from CareDx.
***We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.***
Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy
#LI-Remote
This is the anticipated base salary range in the United States. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience within the job, the type and length of experience within the industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives and restricted stock units. CareDx is a multi-state employer, and this salary range may not reflect positions that work in other states.
Similar Jobs
What We Do
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
